Teva Reports Second Quarter 2021 Financial Results
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
Annual Report 2018 - Canada.ca
PDF) Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry
DEF 14A
PDF) Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry